Seminars in Reproductive Medicine, 6(02), 129-143, 1988
Diagnosis and Treatment of Luteal Phase Deficiency: A Review
Author affiliations
- Uniformed Services University of the Health Sciences ROR
Abstract not indexed. Read at source
Topics
luteal phase deficiency diagnosis treatment review, Fritz luteal phase defect management, luteal phase deficiency infertility treatment options, progesterone supplementation luteal phase defect, ovulatory dysfunction luteal phase deficiency clinical review, endometrial biopsy luteal phase deficiency diagnosis, luteal phase support fertility treatment, corpus luteum insufficiency reproductive endocrinology, luteal phase defect clomiphene progesterone therapy, recurrent pregnancy loss luteal phase deficiency
DOI 10.1055/s-2007-1021349 10.1055/s-2007-1021349
Cite this article
Fritz M (1988). Inadequate Luteal Function and Recurrent Abortion: Diagnosis and Treatment of Luteal Phase Deficiency. Seminars in Reproductive Medicine, 6(02), 129-143. https://doi.org/10.1055/s-2007-1021349
Fritz M. Inadequate Luteal Function and Recurrent Abortion: Diagnosis and Treatment of Luteal Phase Deficiency. Semin Reprod Med. 1988;6(02):129-143. doi:10.1055/s-2007-1021349
Fritz M. "Inadequate Luteal Function and Recurrent Abortion: Diagnosis and Treatment of Luteal Phase Deficiency." Seminars in Reproductive Medicine, vol. 6, no. 02, 1988, pp. 129-143.
Related articles
InfertilityhCG SupplementationTreatmentHormonal Supplementation
Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation
Blumenfeld Z et al., 1992·Fertil Steril
To determine if repetitive administration of hCG causes decreased pregnancy wastage rates in patients who are at a high risk of luteal inadequacy. Ovulation induction using human menopausal gonadotropin (hMG)/human chorionic gonadotropin (hCG) or clomiphene citrate (CC) is associated with luteal phase defects that may cause increased pregnancy wastage. An increased risk of abortion exists also in pregnancies in patients with previous repeated miscarriage, women older than 37 years, and various causes of infertility such as hyperprolactinemia. Because the presumed common denominator to the increased rate of pregnancy wastage in all these cases is luteal dysfunction, repetitive hCG administration, 2,500 U two times weekly, was carried out between the 4th and 8th week of gestation in 249 cases of ovulation induction and/or previous abortions, whereas 198 gestations served as controls (no hCG administration). In the hCG treatment group, 43 ended in miscarriage (17.3%) versus 97 abortions in the control group (49%, P less than 0.01). In 160 cases of hMG/hCG generated gestations, 94 received hCG and 66 did not. The pregnancy wastage rates were 21.3% and 42.4%, respectively (P less than 0.05). In 144 cases of CC/hCG-induced pregnancies, 95 received hCG and 49 served as controls. The respective abortion rates were 15.8% and 44.8% (P less than 0.01). The remaining 143 spontaneous conceptions occurred in infertile patients with previous repeated abortions. In 60 of these conceptions, hCG was administered during the first 4 weeks of gestation and 83 cases served as control. The pregnancy wastage rates were 13.3% versus 56.6%, respectively (P less than 0.001). Repetitive administration of hCG during the early gestation in cases that are at high risk of luteal inadequacy may significantly decrease the pregnancy wastage rate.
InfertilityContaminant Exposure and FertilityBPA Phthalate Pesticide EffectsSemen Quality and Chemical Exposure
Environmental Contaminants Affecting Fertility and Somatic Health
Chiang C et al., 2017·Semin Reprod Med
This review article summarizes the epidemiological findings published between 2011 and 2016 concerning bisphenol A (BPA), phthalates, dioxins, pesticides, air pollution, fracking chemicals, triclosan, and parabens and fertility parameters in men (i.e., semen volume, sperm concentration, sperm motility, and sperm morphology) as well as fertility parameters in women (i.e., cyclicity, fertility treatment outcomes), pregnancy outcomes (i.e., preterm birth,miscarriage), and reproductive disorders (i.e., polycystic ovary syndrome, endometriosis, and uterine fibroids). Overall, this review indicates that several environmental toxicants are significantly associated with reduced fertility parameters in men and women as well as several reproductive disorders in women. Although many studies reported that the selected exposures are associated with adverse fertility outcomes, several studies reported null associations. Thus, future studies are still needed to better elucidate the associations and potential mechanisms between these environmental chemicals and fertility outcomes in men and women.
Research
Disparities in Obstetrical Outcomes in ART Pregnancies Compared with Natural Conceptions
Novak C et al., 2013·Seminars in Reproductive Medicine
Health disparities are observed in all fields of medicine and reproductive health is not immune to this phenomenon. The incidence of women using infertility treatments to conceive is increasing. Women undergoing assisted reproduction appear to be at increased risk of adverse outcomes, and minority women tend to be at even greater risk. This article examines several adverse obstetrical outcomes including preterm birth, congenital malformations, and preeclampsia among women receiving infertility treatments compared with those who conceive spontaneously. It will further examine societal costs associated with these procedures.
AndrologyAntioxidant SupplementationNutritional InterventionsOxidative Stress
Nutrient supplementation: improving male fertility fourfold
Mora-Esteves C et al., 2013·Semin Reprod Med
Oxidative stress can contribute to impairment in spermatogenesis leading to male-factor infertility. The effectiveness of various antioxidants (such as carnitine, vitamin C, vitamin E, selenium, carotenoids, glutathione, N-acetylcysteine, zinc, folic acid, and coenzyme Q10) is variable with respect to improving semen parameters and pregnancy rates. A recent Cochrane review determined that men taking antioxidants had a statistically significant increase in both live birth rates and pregnancy rates. For those undergoing assisted reproduction, the odds ratio that antioxidant use would improve pregnancy rates was 4.18, with a 4.85-fold improvement in live birth rate also noted. Further investigation with randomized, controlled clinical trials is needed to confirm the safety and efficacy of antioxidant supplementation in the medical management and treatment of male infertility.